UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000033004
Receipt No. R000036752
Official scientific title of the study Investigation on EBV infection status and immunosuppressive treatment in Japanese IBD patients
Date of disclosure of the study information 2018/07/01
Last modified on 2018/06/15 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Investigation on EBV infection status and immunosuppressive treatment in Japanese IBD patients
Title of the study (Brief title) EBISU study
Region
Japan

Condition
Condition inflammatory bowel disease
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 In this study, we investigate the EBV antibody titer of patients with IBD including children and clarify the prevalence of EBV infection by age. Then, it compares with the use situation of IBD therapeutic agent, especially thiopurine preparation and biological preparation, and clarifies the actual situation in Japan.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Rate of EBV infection by age in patient with IBD
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patient with IBD of all age.
Key exclusion criteria Patient who can not obtain consent of participation in this study.
Target sample size 510

Research contact person
Name of lead principal investigator Tadakazu Hisamatsu
Organization Kyorin University School of Medicine
Division name The Third Department of Internal Medicine
Address 6-20-2 Shinkawa Mitaka Tokyo
TEL 0422-47-5511
Email thisamatsu@ks.kyorin-u.ac.jp

Public contact
Name of contact person Miki Miura
Organization Kyorin University School of Medicine
Division name The Third Department of Internal Medicine
Address 6-20-2 Shinkawa Mitaka Tokyo
TEL 0422-47-5511
Homepage URL
Email jasmine.miu.m@gmail.com

Sponsor
Institute Kyorin University School of Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 07 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2018 Year 03 Month 02 Day
Anticipated trial start date
2018 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information As a cross sectional observational study, we will clarify the status of EBV infection by age.

Management information
Registered date
2018 Year 06 Month 15 Day
Last modified on
2018 Year 06 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036752